PRP & GFC Hair Treatment in Thiruvalla
Physician-Administered Autologous Growth Factor Therapy for Hair Restoration
PRP and next-generation GFC delivered only by board-certified MD DVL dermatologists at DermaVue Thiruvalla (Tiruvalla). FDA-listed single-use kits, platelet concentration verified at or above 1x10^6 per microlitre per the IADVL 2024 consensus. Serving Thiruvalla, Pathanamthitta, Chengannur, Ranni, Adoor, Pandalam, Kozhencherry, Mallappally, Kumbanad and Aranmula.
PRP & GFC Hair Treatment in Thiruvalla: Quick Answer
PRP (Platelet-Rich Plasma) and GFC (Growth Factor Concentrate) at DermaVue Thiruvalla (Tiruvalla) are autologous injectable therapies for androgenetic alopecia, telogen effluvium and post-transplant recovery, delivered only by board-certified MD DVL dermatologists — never by technicians or nurses — using FDA-listed single-use kits (RegenKit, EmCyte, Arthrex Angel or Dr PRP India). The IADVL 2024 consensus on platelet-rich plasma in dermatology recommends a platelet concentration of at least 1 x 10^6 per microlitre (roughly 4–6x baseline whole blood) for follicular bioactivity; we verify this standard before every injection. Standard protocol is three sessions four weeks apart, followed by maintenance every three to six months. Pricing starts from approximately ₹3,000 per PRP session and ₹5,000–₹8,000 per GFC session, with a written quote issued at the paid consultation.
- Molecules: PRP (platelets + plasma) and GFC (anucleate growth factor concentrate: PDGF-AA/BB, VEGF, EGF, IGF-1, TGF-β)
- Administered by: Board-certified MD DVL dermatologist only, per NMC 2022–23 advisory
- Kit standard: Single-use, FDA-listed closed systems (RegenKit · EmCyte · Arthrex Angel · Dr PRP India)
- Platelet target: ≥ 1 x 10^6 /μL per IADVL 2024 consensus (Mysore et al., IJDVL)
- Protocol: 3 monthly induction sessions, then maintenance every 3–6 months
- Session time: 45–60 minutes including anaesthetic wait, zero downtime
- Price range: PRP ₹3,000 · GFC ₹5,000–₹8,000 per session (written quote at consultation)
- Rating: 4.8★ from 3,221+ verified Google reviews
PRP Hair Restoration Explained by DermaVue Trichologists
Why Choose DermaVue for PRP & GFC in Thiruvalla & Pathanamthitta?
Injectable biologics — including autologous PRP and GFC — fall squarely within the scope of the National Medical Commission 2022–2023 advisory on aesthetic procedures, which restricts such treatments to Registered Medical Practitioners with appropriate qualification. At DermaVue Thiruvalla every draw, spin and injection is performed by a board-certified MD DVL dermatologist using FDA-listed single-use closed-system kits with full lot traceability. Platelet concentration is verified against the IADVL 2024 consensus floor of 1 x 10^6 /μL before any injection is delivered, and all patients are screened for HBV, HCV, HIV and coagulation status in line with Indian transfusion-medicine norms even though the product is autologous.
- Every injection performed by an MD DVL dermatologist trained in trichology and scalp micro-anatomy
- FDA-listed single-use kits only (RegenKit, EmCyte Pure PRP, Arthrex Angel or Dr PRP India). No reused tubes, no open preparation
- Double-spin protocol for high-concentration LP-PRP (leucocyte-poor): lower inflammation, higher platelet yield, as per Dohan Ehrenfest classification
- Pre-treatment HBV, HCV, HIV and complete blood count screening per Indian transfusion-medicine norms
- Platelet concentration quality-checked against the IADVL 2024 consensus minimum of 1 x 10^6 /μL
- Per-session transparent pricing with a written quote at the paid consultation (no "unlimited packages")
- Combination protocols with topical minoxidil, oral finasteride/dutasteride and MNRF microneedling radiofrequency where clinically indicated
- 3,221+ verified Google reviews · 4.8★ rating
- Serving Thiruvalla (Tiruvalla), Pathanamthitta, Chengannur, Ranni, Adoor, Pandalam, Mallappally, Kozhencherry, Kumbanad, Aranmula, Eraviperoor and Kuttapuzha
Clinical Summary: Evidence Base for PRP & GFC in Androgenetic Alopecia
Platelet-rich plasma for androgenetic alopecia is supported by a consistent body of randomised and controlled evidence. Gentile and colleagues (Stem Cells Translational Medicine 2015, Cells 2019) demonstrated a statistically significant increase in hair count and mean hair density at 12 weeks versus placebo in men with male-pattern hair loss, using a half-head randomised design. Cervelli et al. reported analogous density gains in female pattern hair loss. A 2020 Cochrane-style systematic review in the International Journal of Women's Dermatology concluded that PRP produces modest but reproducible density improvements in androgenetic alopecia when platelet concentration exceeds 4x baseline. The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) 2024 consensus, published in the Indian Journal of Dermatology, Venereology and Leprology (IJDVL), codifies the minimum platelet concentration, recommended session count and combination protocols used across Indian practice. GFC — an anucleate, cell-free growth factor concentrate — further refines the approach by eliminating red and white blood cells, reducing procedural inflammation while preserving PDGF, VEGF, EGF, IGF-1 and TGF-β activity.
- Gentile et al., Stem Cells Translational Medicine 2015: Half-head RCT in male AGA showing significant increase in hair count vs placebo at 12 weeks
- Gentile & Garcovich, Cells 2019: Comprehensive review of PRP bioactivity in hair follicle stem cell niche
- Cervelli et al., Biomed Research International 2014: PRP in female pattern hair loss, with measurable density gains
- Rinaldi et al.: LP-PRP (leucocyte-poor) protocols show lower post-procedure inflammation than LR-PRP
- IADVL 2024 Consensus (Mysore et al., IJDVL): Minimum platelet concentration ≥ 1 x 10^6 /μL; 3–6 induction sessions
- Dohan Ehrenfest classification: Defines P-PRP, L-PRP, P-PRF, L-PRF families. DermaVue uses P-PRP / LP-PRP for scalp indications
- GFC rationale: Anucleate concentrate of PDGF-AA, PDGF-BB, VEGF, EGF, IGF-1, TGF-β; preserves signalling without leucocyte-driven inflammation
- Synergy data: PRP combined with topical minoxidil 5% and oral finasteride shows additive density gains (Alves & Grimalt, Int J Trichol 2016)
- Reference: Gentile & Garcovich, Cells 2019 (PubMed)
PRP vs GFC vs LR-PRP vs LP-PRP: Choosing the Right Preparation
Not all "PRP" is clinically equivalent. The molecule depends on the spin protocol, the kit and whether leucocytes are retained. At DermaVue Thiruvalla the preparation is selected by your dermatologist after scalp mapping, trichoscopy and review of your indication, not by a fixed menu.
- Single-spin PRP: Faster, lower platelet concentration (roughly 2–3x baseline); adequate for mild telogen effluvium but below the IADVL 2024 threshold for AGA
- Double-spin PRP: Standard for androgenetic alopecia; achieves 4–6x platelet concentration, meets the ≥ 1 x 10^6 /μL target
- LR-PRP (leucocyte-rich): Higher white-cell content and greater inflammatory signalling; used selectively (some tendon and musculoskeletal indications), less preferred for scalp
- LP-PRP (leucocyte-poor): Preferred for scalp; lower post-injection soreness and erythema, cleaner growth factor release, aligned with Rinaldi and Gentile protocols
- GFC (Growth Factor Concentrate): Anucleate preparation; platelets lysed to release growth factors, red and white cells removed, yielding a pure factor supernatant (PDGF-AA/BB, VEGF, EGF, IGF-1, TGF-β)
- GFC advantages: More predictable dosing, less injection-site inflammation, longer shelf stability within a session, often used when PRP response has plateaued
- Kits used at DermaVue: RegenKit (Regen Lab, Switzerland), EmCyte Pure PRP II (USA), Arthrex Angel (USA) and Dr PRP India. All FDA-listed, single-use, closed-system
- What DermaVue will NOT use: Open tubes, reused centrifuge tubes, unbranded "PRP kits" without FDA listing, or preparations that skip the platelet-count quality check
Who Benefits Most from PRP & GFC at DermaVue Thiruvalla?
PRP and GFC revitalise miniaturising follicles and extend the anagen (growth) phase. They do not regrow follicles in areas of complete scarring alopecia or in Norwood VI–VII baldness. Candidacy is confirmed by trichoscopy, scalp mapping, hormonal workup (where indicated) and a review of prior therapies. Earlier intervention consistently yields better outcomes across the published literature.
- Androgenetic alopecia (Norwood I–IV, Ludwig I–II): Best-responder group; Gentile, Cervelli and IADVL 2024 all report significant density gains
- Telogen effluvium: Post-viral, post-dengue, post-COVID, thyroid-related, iron-deficiency or stress-induced diffuse shedding; responds well once the trigger is corrected
- Postpartum hair loss: Physiological telogen effluvium resolving around month 6–9 post-delivery; PRP accelerates recovery
- PCOS-associated hair thinning: Treated in combination with endocrinology management, topical minoxidil and oral spironolactone/finasteride where indicated
- Alopecia areata (patchy, limited): Adjunct to intralesional steroids; IADVL 2024 lists PRP as a second-line option
- Beard PRP: Patchy beard density; 2–3 sessions with fine-needle micro-injection to the submandibular and cheek zones
- Peri-transplant (FUE / FUT): Pre- and post-transplant PRP improves graft survival and accelerates recovery per the Uebel et al. protocol
- Face PRP (collagen induction): Separate indication; improves texture, fine lines and post-acne erythema. NOT marketed as "vampire facial"
- Not suitable: Active scalp infection, complete scarring alopecia (cicatricial), uncontrolled bleeding disorders, anticoagulant therapy (warfarin, DOACs), pregnancy, lactation, or active malignancy
The PRP/GFC Session at DermaVue Thiruvalla: Step by Step
Every session follows a standardised protocol designed to meet the IADVL 2024 consensus and international transfusion-medicine norms. Total chair time is 45–60 minutes including anaesthetic wait. Patients return to normal activities the same day.
Consultation & trichoscopy
Scalp mapping, trichoscopy with density and diameter assessment, Norwood/Ludwig grading, hormonal and nutritional review, HBV/HCV/HIV/CBC screening.
Sterile blood draw
10–20 ml drawn from the antecubital vein into an FDA-listed anticoagulant tube, the same as any routine blood test, performed by trained staff.
Double-spin centrifugation
Calibrated double-spin protocol to separate plasma, concentrate platelets to ≥ 1 x 10^6 /μL (PRP) or lyse and filter for anucleate concentrate (GFC). Single-use closed-system kit only.
Quality check
Platelet yield verified against the IADVL 2024 consensus floor; lot number and kit batch recorded in your clinical file.
Scalp anaesthesia
Topical anaesthetic cream applied to affected zones with 20 minutes wait for complete numbness. Vibration distraction available on request.
Precise micro-injection
PRP or GFC injected intradermally at 1 cm intervals across miniaturising zones using a 30G needle, delivered by the MD DVL dermatologist.
Post-session protocol
Avoid shampoo for 24 hours, no swimming for 48 hours, no strenuous exercise on the day of treatment, no alcohol for 24 hours, no NSAIDs for 72 hours.
Scheduled review & maintenance
Three induction sessions four weeks apart, density re-assessment with trichoscopy at month 4–6, then maintenance every 3–6 months per IADVL 2024.
Safety Profile & Contraindications
Because PRP and GFC are autologous — derived from your own blood — the risk of allergic reaction or disease transmission is effectively zero. Expected, self-limiting effects include mild scalp tenderness, pinpoint pruritus and transient erythema for 24–48 hours. Technique and kit quality matter far more than the molecule itself, which is why DermaVue restricts delivery to MD DVL dermatologists using only FDA-listed single-use closed-system kits and verifies platelet yield against the IADVL 2024 consensus.
- Absolute contraindications: Pregnancy, lactation, active scalp infection, uncontrolled bleeding disorders (haemophilia, severe thrombocytopenia), active malignancy, sepsis
- Medication contraindications: Warfarin, dabigatran, rivaroxaban, apixaban and other anticoagulants; dermatologist will review safe cessation only with the prescriber
- Relative contraindications: NSAID use within 5 days (may reduce platelet function), aspirin within 7 days, active scalp dermatitis or folliculitis
- Screening: HBV, HCV, HIV serology and complete blood count prior to the first session, per Indian transfusion-medicine norms even for autologous products
- Expected effects: Mild scalp soreness, pinpoint bruising, transient erythema 24–48 hours
- Rare effects: Headache, transient scalp tightness, superficial bruising (all self-limiting)
- No cure claims: PRP and GFC do not "cure" androgenetic alopecia. They slow miniaturisation and improve density; maintenance is required
- Reference: Gentile & Garcovich, Cells 2019 · IADVL 2024 consensus (IJDVL)
Ready for PRP & GFC Hair Treatment in Thiruvalla?
DermaVue Thiruvalla — Iykara Peniel Tower, Opposite Indian Overseas Bank, Thukalassery.
Mon–Sat 9 AM–7 PM | Sun 10 AM–6 PM
GFC PRP Platelet Rich Plasma Hair Treatment
Frequently Asked Questions
Book Your PRP & GFC Hair Treatment in Thiruvalla
Board-certified dermatologists. Hospital-standard OT. US-FDA approved equipment.
Physician-led care — every procedure, every time.
Visit Us at Any of Our 7 Clinics
Internationally certified dermatology care across Kerala and Tamil Nadu.